Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours (Q36150422)

12 August 2017

1 reference

title

Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours (English)

1 reference

12 August 2017

6

Jon D Weingart

1 reference

12 August 2017

7

Henry Brem

1 reference

12 August 2017

Shaan M Raza

1

1 reference

12 August 2017

Gustavo Pradilla

2

1 reference

12 August 2017

Federico G Legnani

3

1 reference

12 August 2017

Quoc Anh Thai

4

1 reference

12 August 2017

Alessandro Olivi

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

477-494

1 reference

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Current and future strategies for the treatment of malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Current chemotherapy for glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Brain and other central nervous system tumors: rates, trends, and epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Targeted therapy for brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Drug delivery systems for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Transporting therapeutics across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Optimizing drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Targeting drugs to the brain by redox chemical delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

New methods of drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Polymers for the sustained release of proteins and other macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Intralesionally implanted cisplatin cures primary brain tumor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Development of microspheres for neurological disorders: from basics to clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Polyanhydrides for controlled release of bioactive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Brain biocompatibility of a biodegradable, controlled-release polymer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Erosion of a new family of biodegradable polyanhydrides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Treatment of intracranial gliomas and metastatic carcinomas by local application of cytostatic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

The intraneoplastic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Preparation and Characterization of 5-Fluorouracil-loaded Microparticles as Biodegradable Anticancer Drug Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

The current status of camptothecin analogues as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Camptothecin analogs in malignant gliomas: comparative analysis and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Mitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Inhibition of tumor angiogenesis mediated by cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Identification of an Inhibitor of Neovascularization from Cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

The role of minocycline in the treatment of intracranial 9L glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Multi-pulse drug delivery from a resorbable polymeric microchip device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Local drug delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Gene transfer with lipospermines and polyethylenimines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Efficient active transport of gene nanocarriers to the cell nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

Vector-mediated drug delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

A controlled-release microchip

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.4.477

21 January 2018

Identifiers

DOI

10.1517/14712598.5.4.477

1 reference

release_jb3gt6iojfac5oxlmeaworhmou

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jb3gt6iojfac5oxlmeaworhmou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference